Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-11 av 11

2019
1 Glover, Joel; Tysnes, Ole-Bjørn; Myhr, Kjell-Morten; Bråthen, Geir; Sandvig, Ioanna; Høyer, Helle; Holmøy, Trygve; Nakken, Ola; Harbo, Hanne Flinstad.
Hvor står ALS-forskningen i Norge?. VG : Verdens gang 2019
UiO UiB NTNU STHF Untitled
 
2 Holmøy, Trygve; Fevang, Børre; Olsen, David Benee; Spigset, Olav; Bø, Lars.
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis. BMC Research Notes 2019 ;Volum 12.(1) s. 1-5
UiO AHUS OUS NTNU STO UiB HAUKELAND Untitled
 
3 Holmøy, Trygve; Fogdell-Hahn, Anna; Svenningsson, Anders.
Serum sickness following rituximab therapy in multiple sclerosis. Neurology: Clinical Practice 2019 ;Volum 9.(6) s. 519-521
UiO AHUS Untitled
 
4 Hupperts, Raymond; Smolders, Joost; Vieth, Reinhold; Holmøy, Trygve; Marhardt, Kurt; Schluep, Myriam; Killestein, Joep; Barkhof, Frederik; Beelke, Manolo; Grimaldi, Luigi M. E..
Randomized trial daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a. Neurology 2019 ;Volum 93.(20) s. E1906-E1916
AHUS UiO Untitled
 
5 Høglund, Rune Alexander; Myro, Aija Zuleron; Zarnovicky, Svetozar; Holmøy, Trygve.
En ung kvinne med krampeanfall, synsforstyrrelser og lammelser. Tidsskrift for Den norske legeforening 2019 ;Volum 139.(11) s. -
UiO AHUS Untitled
 
6 Høglund, Rune Alexander; Torsetnes, Silje Bøen; Lossius, Peter Andreas Vold; Bogen, Bjarne; Homan, E. Jane; Bremel, Robert; Holmøy, Trygve.
Human cysteine cathepsins degrade immunoglobulin G in vitro in a predictable manner. International Journal of Molecular Sciences 2019 ;Volum 20:4843.(19) s. 1-19
UiO AHUS Untitled
 
7 Larsen, Christopher Storm; Myhr, Kjell-Morten; Farbu, Elisabeth; Midgard, Rune; Nyquist, Kaja Beate; Broch, Line; Berg-Hansen, Pål; Buness, A; Holm, Kristian; Ueland, Thor; Fallang, Lars-Egil; Burum-Auensen, Espen; Hov, Johannes Espolin Roksund; Holmøy, Trygve.
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial. Multiple Sclerosis Journal, Experimental, Translational and Clinical 2019 ;Volum 5.(4) s. 1-13
UiB VV OUS NTNU UiO HAUKELAND HMR SUS SI AHUS UiT Untitled
 
8 Myhr, Kjell-Morten; Torkildsen, Øivind; Lossius, Peter Andreas Vold; Bø, Lars; Holmøy, Trygve.
B cell depletion in the treatment of multiple sclerosis. Expert Opinion on Biological Therapy 2019 ;Volum 19.(3) s. 261-271
UiB HAUKELAND UiO OUS AHUS Untitled
 
9 Nakken, Ola; Meyer, Haakon E; Stigum, Hein; Holmøy, Trygve.
High BMI is associated with low ALS risk: A population-based study. Neurology 2019 ;Volum 93.(5) s. e424-e432
FHI AHUS UiO Untitled
 
10 Smolders, Joost; Torkildsen, Øivind; Camu, William; Holmøy, Trygve.
An Update on Vitamin D and Disease Activity in Multiple Sclerosis. CNS Drugs 2019 ;Volum 33.(12) s. 1187-1199
UiB HAUKELAND UiO AHUS Untitled
 
11 Tomescu-Baciu, Alina; Johansen, Jorunn; Holmøy, Trygve; Greiff, Victor; Stensland, Maria; De Souza, Gustavo Antonio; Vartdal, Frode; Lossius, Peter Andreas Vold.
Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis. Journal of Neuroimmunology 2019 ;Volum 333:576966. s. 1-7
OUS UiO AHUS Untitled